Omkar Pharmachem quarterly results and financials

Omkar Pharmachem (BSE 532167)₹5.69+0.53%(9 Nov 2026 close)Commodity Chemicals

Key facts

In the Mar 2026 quarter (standalone), Omkar Pharmachem reported sales of ₹0.10 Cr, down 33.3% from Mar 2025, and net profit of ₹0.01 Cr. For the year to Mar 2026, sales were ₹0.48 Cr and net profit ₹0.11 Cr.

Sales (Mar 2026): ₹0.10 Cr
Net profit (Mar 2026): ₹0.01 Cr
Sales (FY Mar 2026): ₹0.48 Cr
Net profit (FY Mar 2026): ₹0.11 Cr
EPS (Mar 2026): ₹0.03
Borrowings (Mar 2026): ₹0 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Omkar Pharmachem quarterly results

₹ crore unless stated; each column is a quarter.

Omkar Pharmachem Quarterly results
	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.12	0.10
Expenses	0.10	0.06	0.06	0.05	0.10	0.06	0.06	0.06	0.11	0.08	0.08	0.08
Operating Profit	0.06	0.10	0.08	0.09	0.06	0.10	0.10	0.08	0.05	0.08	0.05	0.03
OPM %	35.8%	64.4%	50.1%	57.2%	35.8%	64.4%	64.3%	50.1%	28.6%	50.1%	36.4%	22.3%
Other Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.04	0.00	0.00	0.00	0.03	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.04	0.08	0.06	0.04	0.04	0.08	0.08	0.04	0.03	0.06	0.03	0.01
Tax %	0.0%	0.0%	0.0%	120.0%	0.0%	0.0%	0.0%	140.0%	25.0%	28.5%	25.0%	0.0%
Net Profit	0.04	0.08	0.06	−0.01	0.04	0.08	0.07	−0.01	0.02	0.04	0.02	0.01
EPS (Rs)	0.06	0.10	0.08	−0.03	0.06	0.10	0.09	−0.03	0.04	0.06	0.04	0.03

Omkar Pharmachem profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Omkar Pharmachem Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0.00	0.00	0.00	0.00	0.06	0.28	0.55	0.55	0.55	0.55	0.48	0.52
Expenses	0.13	0.23	0.25	0.39	0.27	0.23	0.28	0.21	0.24	0.23	0.32	0.35
Operating Profit	−0.13	−0.23	−0.25	−0.39	−0.22	0.04	0.28	0.33	0.30	0.31	0.17	0.21
OPM %	—	—	—	—	−420.0%	11.2%	50.1%	59.3%	53.8%	55.7%	34.1%	40.4%
Other Income	0.00	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.02	0.05	0.06	0.07	0.07	0.06	0.04	0.03	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.00	0.00
Profit before tax	−0.11	0.26	−0.24	−0.41	−0.25	−0.02	0.20	0.26	0.25	0.26	0.16	0.13
Tax %	0.0%	18.5%	0.0%	0.0%	0.0%	−866.7%	14.3%	25.9%	23.1%	25.9%	23.5%	—
Exceptional items	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Net Profit	−0.11	0.21	−0.25	−0.41	−0.25	0.21	0.17	0.19	0.18	0.19	0.11	0.09
EPS (Rs)	−0.13	0.23	−0.27	−0.43	−0.27	0.23	0.19	0.21	0.20	0.21	0.13	0.17
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Omkar Pharmachem balance sheet

₹ crore, at each year end.

Omkar Pharmachem Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10.05	10.05	10.06	10.06	10.07	10.06	10.06	10.07	10.07	10.05	10.05	10.06
Reserves	−0.82	−0.94	−0.72	−0.97	−1.38	−1.65	−1.43	−1.25	−1.05	−0.86	−0.66	26.56
Borrowings	0.02	0.00	0.00	0.25	0.59	0.88	0.91	0.94	0.63	0.31	0.13	0.00
Other Liabilities	0.13	0.58	0.07	0.03	0.05	0.06	0.08	0.06	0.08	0.07	0.05	0.04
Total Liabilities	9.38	9.69	9.41	9.37	9.33	9.35	9.62	9.82	9.73	9.57	9.57	36.66
Fixed Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	9.29	9.29	9.29	9.29	9.31	9.29	9.29	9.31	9.31	9.29	9.29	36.36
Other Assets	0.09	0.40	0.12	0.08	0.02	0.06	0.33	0.51	0.42	0.28	0.28	0.30
Trade receivables	0.06	0.06	0.06	0.06	0.00	0.01	0.02	0.07	0.12	0.04	0.09	0.02
Cash & equivalents	0.00	0.32	0.04	0.01	0.01	0.03	0.03	0.20	0.12	0.06	0.10	0.21
Total Assets	9.38	9.69	9.41	9.37	9.33	9.35	9.62	9.82	9.73	9.57	9.57	36.66

Omkar Pharmachem cash flow

₹ crore, for each year.

Omkar Pharmachem Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−0.04	0.33	−0.76	−0.24	−0.29	−0.20	0.01	0.19	0.27	0.29	0.23	0.22
Cash from investing activity	0.00	0.00	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash from financing activity	0.00	0.00	0.00	0.22	0.29	0.23	−0.01	−0.02	−0.34	−0.34	−0.19	−0.11
Net cash flow	−0.04	0.32	−0.27	−0.02	0.00	0.01	0.00	0.16	−0.07	−0.05	0.03	0.10
Capex	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Free cash flow	−0.06	0.35	−0.30	−0.27	−0.31	−0.22	0.03	0.20	0.29	0.30	0.25	0.24
CFO / OP %	82.9%	−283.1%	326.9%	103.9%	78.9%	99.9%	66.9%	74.0%	87.9%	102.9%	79.9%	137.9%

Omkar Pharmachem ratios

Working-capital days and returns, by year.

Omkar Pharmachem Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	—	—	—	—	—	145	40	53	87	33	67	22
Cash conversion cycle	—	—	—	—	—	147	42	55	89	35	69	24
Working capital days	—	—	—	—	—	−6,569	−1,270	−607	−378	−161	−6	24
ROCE %	−0.6%	−1.3%	−2.3%	−2.6%	−4.1%	−2.3%	0.3%	2.8%	3.3%	3.0%	3.1%	0.8%

Omkar Pharmachem: frequently asked questions

What are the latest quarterly results of Omkar Pharmachem?

For the Mar 2026 quarter, Omkar Pharmachem reported sales of ₹0.10 Cr, down 33.3% year on year and net profit of ₹0.01 Cr. The operating margin was 22.3%.

What is the annual revenue of Omkar Pharmachem?

Omkar Pharmachem's sales for the year to Mar 2026 were ₹0.48 Cr; over the last twelve months they were ₹0.52 Cr.

What is the net profit of Omkar Pharmachem?

Net profit for the year to Mar 2026 was ₹0.11 Cr, and ₹0.09 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.17.

How much debt does Omkar Pharmachem have?

Omkar Pharmachem reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0.21 Cr.

What is the free cash flow of Omkar Pharmachem?

Cash from operations was ₹0.22 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.24 Cr.

Loading…